Frazier Lifesciences Acquisition Corp Quarterly Operating Income (Loss) in USD from Q4 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Frazier Lifesciences Acquisition Corp quarterly/annual Operating Income (Loss) history and growth rate from Q4 2020 to Q3 2022.
  • Frazier Lifesciences Acquisition Corp Operating Income (Loss) for the quarter ending September 30, 2022 was -$2.29M, a 521% decline year-over-year.
  • Frazier Lifesciences Acquisition Corp Operating Income (Loss) for the twelve months ending September 30, 2022 was -$5.08M, a 389% decline year-over-year.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$5.08M -$2.29M -$1.92M -521% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$3.16M -$1.99M -$1.69M -552% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 -$1.47M -$345K -$107K -45.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 -$1.37M -$455K -$327K -256% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-25
Q3 2021 -$1.04M -$369K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$305K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$237K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$128K Oct 7, 2020 Dec 31, 2020 10-K 2022-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.